ADMEDES, founded in 1996, is a prominent force in the Health Care industry, specializing as a global contract manufacturer of finished Nitinol self-expandable implants, particularly stents and heart valve frames. Headquartered in Germany, ADMEDES leverages cutting-edge micro-machining and surface finishing techniques to offer rapid response prototypes, pilot lines, and full-scale manufacturing services.
The company's innovation extends into a specialized business unit, ADMEDES Microassembly, dedicated to enhancing medical devices from Nitinol for neuromodulation and cardiac rhythm management. This comprehensive capability in both tube processing and advanced wire technologies (forming, braiding, and winding) positions ADMEDES as a leader in the market, supplying approximately half a million NiTi implants annually worldwide.
With a focus on innovation and operational excellence, ADMEDES represents a compelling opportunity for investors seeking to support advancements in the medical device sector.